$0.145000
-0.0082-5.66%
At close: Jun 28, 3:58 PM EDT
$0.140000
-0.0050-3.45%
After Hours: 8:00 AM EDT
15 minutes delayed
Galera Therapeutics
GRTXOTCPK
Galera Therapeutics (OTC:GRTX) Stock, Analyst Ratings, Price Targets, Predictions
Galera Therapeutics Inc has a consensus price target of $4.61, established from looking at the 14 latest analyst ratings. The last 3 analyst ratings were released from Citigroup, HC Wainwright & Co., and Piper Sandler on August 29, 2023, August 16, 2023, and August 10, 2023. With an average price target of $0.35 between Citigroup, HC Wainwright & Co., and Piper Sandler, there's an implied 155.85% upside for Galera Therapeutics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Citigroup
HC Wainwright & Co.
Piper Sandler
B of A Securities
BTIG
1calculated from analyst ratings
Analyst Ratings for Galera Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 08/29/2023 | Buy Now | 82.75% | Citigroup | Yigal Nochomovitz | $0.4 → $0.25 | Maintains | Neutral | Get Alert |
| 08/16/2023 | Buy Now | 119.3% | HC Wainwright & Co. | Raghuram Selvaraju | $6 → $0.3 | Downgrade | Buy → Neutral | Get Alert |
| 08/10/2023 | Buy Now | 265.5% | Piper Sandler | Edward Tenthoff | $6 → $0.5 | Downgrade | Overweight → Neutral | Get Alert |
| 07/17/2023 | Buy Now | 4285.96% | HC Wainwright & Co. | Raghuram Selvaraju | → $6 | Reiterates | Buy → Buy | Get Alert |
| 03/22/2023 | Buy Now | 4285.96% | HC Wainwright & Co. | Raghuram Selvaraju | $10 → $6 | Maintains | Buy | Get Alert |
| 02/21/2023 | Buy Now | 4285.96% | Piper Sandler | Edward Tenthoff | → $6 | Initiates | → Overweight | Get Alert |
| 02/16/2023 | Buy Now | 5016.96% | B of A Securities | Tazeen Ahmad | $2 → $7 | Upgrade | Underperform → Buy | Get Alert |
| 02/16/2023 | Buy Now | 7209.94% | HC Wainwright & Co. | Raghuram Selvaraju | → $10 | Reiterates | → Buy | Get Alert |
| 05/27/2022 | Buy Now | 1361.99% | B of A Securities | Tazeen Ahmad | → $2 | Downgrade | Neutral → Underperform | Get Alert |
| 12/20/2021 | Buy Now | 14519.88% | Citigroup | Yigal Nochomovitz | — | Maintains | Buy | Get Alert |
| 12/15/2021 | Buy Now | 7209.94% | HC Wainwright & Co. | Raghuram Selvaraju | — | Upgrade | Neutral → Buy | Get Alert |
| 12/15/2021 | Buy Now | 10864.91% | BTIG | Robert Hazlett | — | Upgrade | Neutral → Buy | Get Alert |
| 10/20/2021 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju | — | Downgrade | Buy → Neutral | Get Alert |
| 10/19/2021 | Buy Now | — | BTIG | Robert Hazlett | — | Downgrade | Buy → Neutral | Get Alert |
FAQ
What is the target price for Galera Therapeutics (GRTX) stock?
The latest price target for Galera Therapeutics (OTCPK:GRTX) was reported by Citigroup on August 29, 2023. The analyst firm set a price target for $0.25 expecting GRTX to rise to within 12 months (a possible 82.75% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Galera Therapeutics (GRTX)?
The latest analyst rating for Galera Therapeutics (OTCPK:GRTX) was provided by Citigroup, and Galera Therapeutics maintained their neutral rating.
When was the last upgrade for Galera Therapeutics (GRTX)?
The last upgrade for Galera Therapeutics Inc happened on February 16, 2023 when B of A Securities raised their price target to $7. B of A Securities previously had an underperform for Galera Therapeutics Inc.
When was the last downgrade for Galera Therapeutics (GRTX)?
The last downgrade for Galera Therapeutics Inc happened on August 16, 2023 when HC Wainwright & Co. changed their price target from $6 to $0.3 for Galera Therapeutics Inc.
When is the next analyst rating going to be posted or updated for Galera Therapeutics (GRTX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Galera Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Galera Therapeutics was filed on August 29, 2023 so you should expect the next rating to be made available sometime around August 29, 2024.
Is the Analyst Rating Galera Therapeutics (GRTX) correct?
While ratings are subjective and will change, the latest Galera Therapeutics (GRTX) rating was a maintained with a price target of $0.40 to $0.25. The current price Galera Therapeutics (GRTX) is trading at is $0.14, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.